Low-ogestrel
Product Images NDC 53002-1637

6 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Low-ogestrel (NDC 53002-1637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lowogestrel 01)

Chemical Structure (Lowogestrel 01)
Chemical structure of the active ingredient in Low-Ogestrel, illustrating a steroid hormone framework with specific chemical groups including hydroxyl and ketone functionalities.*
FDA Label Image

Chemical Structure (Lowogestrel 02)

Chemical Structure (Lowogestrel 02)
Chemical structure of Low-Ogestrel, illustrating a steroidal compound with hydroxyl groups, methyl substitutions, and a substituted cyclopentene ring as part of the molecular framework.*
FDA Label Image

Figure 1 (Lowogestrel 02a)

Figure 1 (Lowogestrel 02a)
A forest plot chart titled 'Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives' showing effect estimates from various studies comparing the risk of breast cancer among combined oral contraceptive (COC) users versus never users. The chart includes study names, study years, and effect estimates presented as odds ratios (OR), relative risks (RR), or hazard ratios (HR) plotted along a horizontal axis ranging from -1.5 to 2.0. Confidence intervals are depicted for each estimate.*
FDA Label Image

Image (Lowogestrel 03)

Image (Lowogestrel 03)
A bar chart showing mortality rate (number of deaths per 100,000 woman years) across different age groups (15-24, 25-34, 35-44, 45 and older). It compares four categories: ever-users who are non-smokers, ever-users who are smokers, controls who are non-smokers, and controls who are smokers, with mortality rates increasing significantly for ever-users who are smokers especially in older age groups.*
FDA Label Image

Image (Lowogestrel 04)

Image (Lowogestrel 04)
An illustrated tablet calendar for Low-Ogestrel, showing a weekly circle layout from Sunday to Saturday across four rows labeled 1 to 4. Each day has a circle with arrows guiding the sequence to follow. The fourth row indicates the tablets are inactive. The active ingredients, norgestrel and ethinyl estradiol, are noted below the calendar for reference.*
FDA Label Image

Label Image (Lbl530021637)

Label Image (Lbl530021637)
Low-Ogestrel Tablets 28 Day regimen label with 28 tablets; instructs to take 1 tablet daily as directed. The label includes prescription information fields such as patient name and clinic name, directions, and barcodes. Manufactured by RPK Pharmaceuticals, Inc. Product NDC 53002-1637.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.